OCR

WHITE PAPERS AND CASE STUDIES

• WuXiHigh 2.0 Delivers A 180 mg/mL Formula

  This case study shows how smart formulation and integrated development achieved a stable 180 mg/mL biologic for subcutaneous delivery, for teams tackling concentration issues.

• Duchenne Muscular Dystrophy Trial In China

  A global sponsor conducting a Duchenne Muscular Dystrophy trial in China required reliable patient travel solutions to support children and families.

• Advanced SWIR Sensor Development At SUI

  Explore advancements in SWIR sensor technologies, enhancing time-of-flight imaging, avalanche photodetectors, and quenching circuits for high-performance applications in precision targeting, 3D LADAR, and photon detection.

• Transferring From Microfluidics To A Turbulent Mixer

  What solutions did the client featured in this case study find when they sought help in transferring their formulation process to a turbulent Impinged Jet Mixing (IJM)?

• Increasing Productivity On The Production Line With Laser Power Measurement

  Dive into how one company's adoption of reliable laser output measurement on its production lines led to increased productivity and cost-efficiency.

• Manufacturing Transfers: Delivering 140+ Precision Medical Devices Without Missing A Deadline

  Go inside a successful manufacturing transfer of over 140 Class-III silicone medical devices and on-time delivery for a top-30 OEM through expert project management and rigorous validation processes.

• Optimized Stability Storage

  A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.

• Sensing Beyond Limits: Transforming User Experience With UWB Radar

  Ultra-Wideband radar sensing enables low-power, high-precision presence, motion, and vital-sign detection, unlocking smarter automotive, smart-home, and healthcare applications beyond traditional ranging.

• Multiple Fill Line Delivery Experience

  Learn how a multinational pharmaceutical company successfully implemented a global strategy for insulin cartridge filling, achieving seamless regulatory approval with zero deviations.

• Designing, Selecting, And Developing Bioconjugates For Clinical Success

  Accelerate the development of complex bioconjugates to unlock new possibilities for targeted therapies and advance the next generation of precision medicine.

• Achieving Complete Destruction Of PFAS Using electraCLEAR Process

  In early 2023, Lacks Enterprises Inc., a large automotive component supplier in the midwestern US, engaged Axine to address destruction of legacy PFAS compounds in wastewater from its manufacturing processes.

• Tracing PS80: How LC‑MS Resolved A Potency Discrepancy

  A targeted LC–MS investigation identifies molecular changes behind potency discrepancies, enabling accurate root‑cause analysis and stronger control of monoclonal antibody product quality.